Rat Model Market was valued US$ 624.84 Mn in 2022 and is expected to reach US$ 1075.04 Mn by 2029, at a CAGR of 8.06 % during a forecast period. Rat model is used for research in biomedical science and psychology. Rats and humans have numerous similarities like physiology, similar body organs, similar genetic structure to humans and frequently suffer from the same diseases. An increase in usage of the rat model in biomedical research for understanding the current health issues is boosting the growth in the market. Continuous research and development activities, research funding and grants and introduction of personalized medicine are the prime factors behind the growth of the rat model market. On the other hand, Fimmoral practices of animal model systems in research and changing rules and regulations on animal testing are limiting the growth of the rat model market.To know about the Research Methodology :- Request Free Sample Report Inbred rats are segment is expected to contribute significant share in the global rat model market. The maximum share in the market is attributed to the rise in usage of the inbred rat models to study various complex disorders like cardiovascular disorders, cancer research, and neurodegenerative disorders. CRISPR technology is expected to hold the dominant position in the global rat model market. The demand for CRISPR technology among researchers is increasing because of some factors like potential reduction in animal usage, cost-effectiveness, and time savings. CRISPR technology is also expected to cover the way for any number of new genetic rat models, which are mainly used for neuroscience research and new genetic models. The toxicology settings segment is expected to contribute maximum share in the market. Toxicology is the study of the adversative effects of chemical, physical, or biological agents on people, animals, and the environment. Rats are mostly used in the toxicity and safety assessment studies of a drug constituent. Toxicology testing in animals is necessary to demonstrate the new drugs are safe before their utilization in humans. Region-wise, The North America region is estimated to hold the dominant position in the global rat model market. The presence of biotech and pharmaceutical companies, along with recognized research and development institutes are expected to drive the market growth in the region. An Increase in demand for rats in pre-clinical animal trail studies by CROs, pharmaceutical companies, and life science research institutions and availability of rat models are some of the factors behind the market growth in North America. The objective of the report is to present a comprehensive analysis of Global Rat Model Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Rat Model Market dynamics, structure by analysing the market segments and project the Global Rat Model Market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Rat Model Market make the report investor’s guide. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
Rat Model Market Scope: Inquire before buying
Global Rat Model Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 624.84 Mn. Forecast Period 2023 to 2029 CAGR: 8.06% Market Size in 2029: US $ 1075.04 Mn. Segments Covered: by Model Type Outbred Rats Inbred Rats Knockout/Genetically Modified Rats Hybrid/Congenic Rats Conditioned/Surgically Modified Rats Immunodeficient Rats by Service Breeding Cryopreservation Quarantine Rederivation Model-in-licensing Genetic Testing Other Services by Technology CRISPR Microinjection Embryonic Stem Cell Nuclear Transfer by Therapeutic Area Toxicology Oncology Immunology and Inflammation Neurology Diabetes Other Therapeutic Areas by Care Product Cages Feed Bedding Other Care Products by End-User Pharmaceutical & Biotechnology Companies Academic & Research Institutes Contract Research Organizations Rat Model Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Rat Model Market Key Players
1.Genoway S.A. 2.Biomere 3.Transposagen Biopharmaceuticals, Inc. 4.Horizon Discovery Group PLC 5.Transviragen, Inc. 6.Charles River Laboratories International, Inc. 7.Taconic Biosciences, Inc. 8.Envigo 9.Laboratory Corporation of America Holdings 10.Janvier Labs 11.Harlan Laboratories, Inc. 12.SAGE Labs 13.Applied StemCell 14.Regenera Pharma 15.Active C60 Frequently Asked Questions: 1. Which region has the largest share in Global Rat Model Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Rat Model Market? Ans: The Global market is growing at a CAGR of 8.06% during forecasting period 2023-2029. 3. What is scope of the Global Rat Model market report? Ans: GlobalMarket report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Rat Model market? Ans: The important key players in the Global Market are – Genoway S.A., Biomere, Transposagen Biopharmaceuticals, Inc., Horizon Discovery Group PLC, Transviragen, Inc., Charles River Laboratories International, Inc., Taconic Biosciences, Inc., Envigo, Laboratory Corporation of America Holdings, Janvier Labs, Harlan Laboratories, Inc., SAGE Labs, Applied StemCell, Regenera Pharma, and Active C60. 5. What is the study period of this market? Ans: The Global Market is studied from 2022 to 2029.
Global Rat Model Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Rat Model Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Rat Model Market Analysis and Forecast 6.1. Global Rat Model Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Rat Model Market Analysis and Forecast, by Model Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Rat Model Market Value Share Analysis, by Model Type 7.4. Global Rat Model Market Size (US$ Mn) Forecast, by Model Type 7.5. Global Rat Model Market Analysis, by Model Type 7.6. Global Rat Model Market Attractiveness Analysis, by Model Type 8. Global Rat Model Market Analysis and Forecast, by Service 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Rat Model Market Value Share Analysis, by Service 8.4. Global Rat Model Market Size (US$ Mn) Forecast, by Service 8.5. Global Rat Model Market Analysis, by Service 8.6. Global Rat Model Market Attractiveness Analysis, by Service 9. Global Rat Model Market Analysis and Forecast, by Therapeutic Area 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Rat Model Market Value Share Analysis, by Therapeutic Area 9.4. Global Rat Model Market Size (US$ Mn) Forecast, by Therapeutic Area 9.5. Global Rat Model Market Analysis, by Therapeutic Area 9.6. Global Rat Model Market Attractiveness Analysis, by Therapeutic Area 10. Global Rat Model Market Analysis and Forecast, by Care Product 10.1. Introduction and Definition 10.2. Key Findings 10.3. Global Rat Model Market Value Share Analysis, by Care Product 10.4. Global Rat Model Market Size (US$ Mn) Forecast, by Care Product 10.5. Global Rat Model Market Analysis, by Care Product 10.6. Global Rat Model Market Attractiveness Analysis, by Care Product 11. Global Rat Model Market Analysis and Forecast, by End-user 11.1. Introduction and Definition 11.2. Key Findings 11.3. Global Rat Model Market Value Share Analysis, by End-user 11.4. Global Rat Model Market Size (US$ Mn) Forecast, by End-user 11.5. Global Rat Model Market Analysis, by End-user 11.6. Global Rat Model Market Attractiveness Analysis, by End-user 12. Global Rat Model Market Analysis and Forecast, by Technology 12.1. Introduction and Definition 12.2. Key Findings 12.3. Global Rat Model Market Value Share Analysis, by Technology 12.4. Global Rat Model Market Size (US$ Mn) Forecast, by Technology 12.5. Global Rat Model Market Analysis, by Technology 12.6. Global Rat Model Market Attractiveness Analysis, by Technology 13. Global Rat Model Market Analysis, by Region 13.1. Global Rat Model Market Value Share Analysis, by Region 13.2. Global Rat Model Market Size (US$ Mn) Forecast, by Region 13.3. Global Rat Model Market Attractiveness Analysis, by Region 14. North America Rat Model Market Analysis 14.1. Key Findings 14.2. North America Rat Model Market Overview 14.3. North America Rat Model Market Value Share Analysis, by Model Type 14.4. North America Rat Model Market Forecast, by Model Type 14.4.1. Outbred Rats 14.4.2. Inbred Rats 14.4.3. Knockout/Genetically Modified Rats 14.4.4. Hybrid/Congenic Rats 14.4.5. Conditioned/Surgically Modified Rats 14.4.6. Immunodeficient Rats 14.5. North America Rat Model Market Value Share Analysis, by Service 14.6. North America Rat Model Market Forecast, by Service 14.6.1. Breeding 14.6.2. Cryopreservation 14.6.3. Quarantine 14.6.4. Rederivation 14.6.5. Model-in-licensing 14.6.6. Genetic Testing 14.6.7. Other Services 14.7. North America Rat Model Market Value Share Analysis, by Therapeutic Area 14.8. North America Rat Model Market Forecast, by Therapeutic Area 14.8.1. Toxicology 14.8.2. Oncology 14.8.3. Immunology and Inflammation 14.8.4. Neurology 14.8.5. Diabetes 14.8.6. Other Therapeutic Areas 14.9. North America Rat Model Market Value Share Analysis, by Care Product 14.10. North America Rat Model Market Forecast, by Care Product 14.10.1. Cages 14.10.2. Feed 14.10.3. Bedding 14.10.4. Others 14.11. North America Rat Model Market Value Share Analysis, by End-user 14.12. North America Rat Model Market Forecast, by End-user 14.12.1. Pharmaceutical & Biotechnology Companies 14.12.2. Academic & Research Institutes 14.12.3. Contract Research Organizations (CROs) 14.13. North America Rat Model Market Value Share Analysis, by Technology 14.14. North America Rat Model Market Forecast, by Technology 14.14.1. CRISPR 14.14.2. Microinjection 14.14.3. Embryonic Stem Cell 14.14.4. Nuclear Transfer 14.15. North America Rat Model Market Value Share Analysis, by Country 14.16. North America Rat Model Market Forecast, by Country 14.16.1. U.S. 14.16.2. Canada 14.17. North America Rat Model Market Analysis, by Country 14.18. U.S. Rat Model Market Forecast, by Model Type 14.18.1. Outbred Rats 14.18.2. Inbred Rats 14.18.3. Knockout/Genetically Modified Rats 14.18.4. Hybrid/Congenic Rats 14.18.5. Conditioned/Surgically Modified Rats 14.18.6. Immunodeficient Rats 14.19. U.S. Rat Model Market Forecast, by Service 14.19.1. Breeding 14.19.2. Cryopreservation 14.19.3. Quarantine 14.19.4. Rederivation 14.19.5. Model-in-licensing 14.19.6. Genetic Testing 14.19.7. Other Services 14.20. U.S. Rat Model Market Forecast, by Therapeutic Area 14.20.1. Toxicology 14.20.2. Oncology 14.20.3. Immunology and Inflammation 14.20.4. Neurology 14.20.5. Diabetes 14.20.6. Other Therapeutic Areas 14.21. U.S. Rat Model Market Forecast, by Care Product 14.21.1. Cages 14.21.2. Feed 14.21.3. Bedding 14.21.4. Others 14.22. U.S. Rat Model Market Forecast, by End-user 14.22.1. Pharmaceutical & Biotechnology Companies 14.22.2. Academic & Research Institutes 14.22.3. Contract Research Organizations (CROs) 14.23. U.S. Rat Model Market Forecast, by Technology 14.23.1. CRISPR 14.23.2. Microinjection 14.23.3. Embryonic Stem Cell 14.23.4. Nuclear Transfer 14.24. Canada Rat Model Market Forecast, by Model Type 14.24.1. Outbred Rats 14.24.2. Inbred Rats 14.24.3. Knockout/Genetically Modified Rats 14.24.4. Hybrid/Congenic Rats 14.24.5. Conditioned/Surgically Modified Rats 14.24.6. Immunodeficient Rats 14.25. Canada Rat Model Market Forecast, by Service 14.25.1. Breeding 14.25.2. Cryopreservation 14.25.3. Quarantine 14.25.4. Rederivation 14.25.5. Model-in-licensing 14.25.6. Genetic Testing 14.25.7. Other Services 14.26. Canada Rat Model Market Forecast, by Therapeutic Area 14.26.1. Toxicology 14.26.2. Oncology 14.26.3. Immunology and Inflammation 14.26.4. Neurology 14.26.5. Diabetes 14.26.6. Other Therapeutic Areas 14.27. Canada Rat Model Market Forecast, by Care Product 14.27.1. Cages 14.27.2. Feed 14.27.3. Bedding 14.27.4. Others 14.28. Canada Rat Model Market Forecast, by End-user 14.28.1. Pharmaceutical & Biotechnology Companies 14.28.2. Academic & Research Institutes 14.28.3. Contract Research Organizations (CROs) 14.29. Canada Rat Model Market Forecast, by Technology 14.29.1. CRISPR 14.29.2. Microinjection 14.29.3. Embryonic Stem Cell 14.29.4. Nuclear Transfer 14.30. North America Rat Model Market Attractiveness Analysis 14.30.1. By Model Type 14.30.2. By Service 14.30.3. By Therapeutic Area 14.30.4. By Care Product 14.30.5. By End-user 14.31. PEST Analysis 14.32. Key Trends 14.33. Key Developments 15. Europe Rat Model Market Analysis 15.1. Key Findings 15.2. Europe Rat Model Market Overview 15.3. Europe Rat Model Market Value Share Analysis, by Model Type 15.4. Europe Rat Model Market Forecast, by Model Type 15.4.1. Outbred Rats 15.4.2. Inbred Rats 15.4.3. Knockout/Genetically Modified Rats 15.4.4. Hybrid/Congenic Rats 15.4.5. Conditioned/Surgically Modified Rats 15.4.6. Immunodeficient Rats 15.5. Europe Rat Model Market Value Share Analysis, by Service 15.6. Europe Rat Model Market Forecast, by Service 15.6.1. Breeding 15.6.2. Cryopreservation 15.6.3. Quarantine 15.6.4. Rederivation 15.6.5. Model-in-licensing 15.6.6. Genetic Testing 15.6.7. Other Services 15.7. Europe Rat Model Market Value Share Analysis, by Therapeutic Area 15.8. Europe Rat Model Market Forecast, by Therapeutic Area 15.8.1. Toxicology 15.8.2. Oncology 15.8.3. Immunology and Inflammation 15.8.4. Neurology 15.8.5. Diabetes 15.8.6. Other Therapeutic Areas 15.8.7. Europe Rat Model Market Value Share Analysis, by Care Product 15.9. Europe Rat Model Market Forecast, by Care Product 15.9.1. Cages 15.9.2. Feed 15.9.3. Bedding 15.9.4. Others 15.10. Europe Rat Model Market Value Share Analysis, by End-user 15.11. Europe Rat Model Market Forecast, by End-user 15.11.1. Pharmaceutical & Biotechnology Companies 15.11.2. Academic & Research Institutes 15.11.3. Contract Research Organizations (CROs) 15.12. Europe Rat Model Market Value Share Analysis, by Technology 15.13. Europe Rat Model Market Forecast, by Technology 15.13.1. CRISPR 15.13.2. Microinjection 15.13.3. Embryonic Stem Cell 15.13.4. Nuclear Transfer 15.14. Europe Rat Model Market Value Share Analysis, by Country 15.15. Europe Rat Model Market Forecast, by Country 15.15.1. Germany 15.15.2. U.K. 15.15.3. France 15.15.4. Italy 15.15.5. Spain 15.15.6. Rest of Europe 15.16. Europe Rat Model Market Analysis, by Country 15.17. Germany Rat Model Market Forecast, by Model Type 15.17.1. Outbred Rats 15.17.2. Inbred Rats 15.17.3. Knockout/Genetically Modified Rats 15.17.4. Hybrid/Congenic Rats 15.17.5. Conditioned/Surgically Modified Rats 15.17.6. Immunodeficient Rats 15.18. Germany Rat Model Market Forecast, by Service 15.18.1. Breeding 15.18.2. Cryopreservation 15.18.3. Quarantine 15.18.4. Rederivation 15.18.5. Model-in-licensing 15.18.6. Genetic Testing 15.18.7. Other Services 15.19. Germany Rat Model Market Forecast, by Therapeutic Area 15.19.1. Toxicology 15.19.2. Oncology 15.19.3. Immunology and Inflammation 15.19.4. Neurology 15.19.5. Diabetes 15.19.6. Other Therapeutic Areas 15.20. Germany Rat Model Market Forecast, by Care Product 15.20.1. Cages 15.20.2. Feed 15.20.3. Bedding 15.20.4. Others 15.21. Germany Rat Model Market Forecast, by End-user 15.21.1. Pharmaceutical & Biotechnology Companies 15.21.2. Academic & Research Institutes 15.21.3. Contract Research Organizations (CROs) 15.22. Germany Rat Model Market Forecast, by Technology 15.22.1. CRISPR 15.22.2. Microinjection 15.22.3. Embryonic Stem Cell 15.22.4. Nuclear Transfer 15.23. U.K. Rat Model Market Forecast, by Model Type 15.23.1. Outbred Rats 15.23.2. Inbred Rats 15.23.3. Knockout/Genetically Modified Rats 15.23.4. Hybrid/Congenic Rats 15.23.5. Conditioned/Surgically Modified Rats 15.23.6. Immunodeficient Rats 15.24. U.K. Rat Model Market Forecast, by Service 15.24.1. Breeding 15.24.2. Cryopreservation 15.24.3. Quarantine 15.24.4. Rederivation 15.24.5. Model-in-licensing 15.24.6. Genetic Testing 15.24.7. Other Services 15.25. U.K. Rat Model Market Forecast, by Therapeutic Area 15.25.1. Toxicology 15.25.2. Oncology 15.25.3. Immunology and Inflammation 15.25.4. Neurology 15.25.5. Diabetes 15.25.6. Other Therapeutic Areas 15.26. U.K. Rat Model Market Forecast, by Care Product 15.26.1. Cages 15.26.2. Feed 15.26.3. Bedding 15.26.4. Others 15.27. U.K. Rat Model Market Forecast, by End-user 15.27.1. Pharmaceutical & Biotechnology Companies 15.27.2. Academic & Research Institutes 15.27.3. Contract Research Organizations (CROs) 15.28. U.K. Rat Model Market Forecast, by Technology 15.28.1. CRISPR 15.28.2. Microinjection 15.28.3. Embryonic Stem Cell 15.28.4. Nuclear Transfer 15.29. France Rat Model Market Forecast, by Model Type 15.29.1. Outbred Rats 15.29.2. Inbred Rats 15.29.3. Knockout/Genetically Modified Rats 15.29.4. Hybrid/Congenic Rats 15.29.5. Conditioned/Surgically Modified Rats 15.29.6. Immunodeficient Rats 15.30. France Rat Model Market Forecast, by Service 15.30.1. Breeding 15.30.2. Cryopreservation 15.30.3. Quarantine 15.30.4. Rederivation 15.30.5. Model-in-licensing 15.30.6. Genetic Testing 15.30.7. Other Services 15.31. France Rat Model Market Forecast, by Therapeutic Area 15.31.1. Toxicology 15.31.2. Oncology 15.31.3. Immunology and Inflammation 15.31.4. Neurology 15.31.5. Diabetes 15.31.6. Other Therapeutic Areas 15.32. France Rat Model Market Forecast, by Care Product 15.32.1. Cages 15.32.2. Feed 15.32.3. Bedding 15.32.4. Others 15.33. France Rat Model Market Forecast, by End-user 15.33.1. Pharmaceutical & Biotechnology Companies 15.33.2. Academic & Research Institutes 15.33.3. Contract Research Organizations (CROs) 15.34. France Rat Model Market Forecast, by Technology 15.34.1. CRISPR 15.34.2. Microinjection 15.34.3. Embryonic Stem Cell 15.34.4. Nuclear Transfer 15.35. Italy Rat Model Market Forecast, by Model Type 15.35.1. Outbred Rats 15.35.2. Inbred Rats 15.35.3. Knockout/Genetically Modified Rats 15.35.4. Hybrid/Congenic Rats 15.35.5. Conditioned/Surgically Modified Rats 15.35.6. Immunodeficient Rats 15.36. Italy Rat Model Market Forecast, by Service 15.36.1. Breeding 15.36.2. Cryopreservation 15.36.3. Quarantine 15.36.4. Rederivation 15.36.5. Model-in-licensing 15.36.6. Genetic Testing 15.36.7. Other Services 15.37. Italy Rat Model Market Forecast, by Therapeutic Area 15.37.1. Toxicology 15.37.2. Oncology 15.37.3. Immunology and Inflammation 15.37.4. Neurology 15.37.5. Diabetes 15.37.6. Other Therapeutic Areas 15.38. Italy Rat Model Market Forecast, by Care Product 15.38.1. Cages 15.38.2. Feed 15.38.3. Bedding 15.38.4. Others 15.39. Italy Rat Model Market Forecast, by End-user 15.39.1. Pharmaceutical & Biotechnology Companies 15.39.2. Academic & Research Institutes 15.39.3. Contract Research Organizations (CROs) 15.40. Italy Rat Model Market Forecast, by Technology 15.40.1. CRISPR 15.40.2. Microinjection 15.40.3. Embryonic Stem Cell 15.40.4. Nuclear Transfer 15.41. Spain Rat Model Market Forecast, by Model Type 15.41.1. Outbred Rats 15.41.2. Inbred Rats 15.41.3. Knockout/Genetically Modified Rats 15.41.4. Hybrid/Congenic Rats 15.41.5. Conditioned/Surgically Modified Rats 15.41.6. Immunodeficient Rats 15.42. Spain Rat Model Market Forecast, by Service 15.42.1. Breeding 15.42.2. Cryopreservation 15.42.3. Quarantine 15.42.4. Rederivation 15.42.5. Model-in-licensing 15.42.6. Genetic Testing 15.42.7. Other Services 15.43. Spain Rat Model Market Forecast, by Therapeutic Area 15.43.1. Toxicology 15.43.2. Oncology 15.43.3. Immunology and Inflammation 15.43.4. Neurology 15.43.5. Diabetes 15.43.6. Other Therapeutic Areas 15.44. Spain Rat Model Market Forecast, by Care Product 15.44.1. Cages 15.44.2. Feed 15.44.3. Bedding 15.44.4. Others 15.45. Spain Rat Model Market Forecast, by End-user 15.45.1. Pharmaceutical & Biotechnology Companies 15.45.2. Academic & Research Institutes 15.45.3. Contract Research Organizations (CROs) 15.46. Germany Rat Model Market Forecast, by Technology 15.46.1. CRISPR 15.46.2. Microinjection 15.46.3. Embryonic Stem Cell 15.46.4. Nuclear Transfer 15.47. Rest of Europe Rat Model Market Forecast, by Model Type 15.47.1. Outbred Rats 15.47.2. Inbred Rats 15.47.3. Knockout/Genetically Modified Rats 15.47.4. Hybrid/Congenic Rats 15.47.5. Conditioned/Surgically Modified Rats 15.47.6. Immunodeficient Rats 15.48. Rest of Europe Rat Model Market Forecast, by Service 15.48.1. Breeding 15.48.2. Cryopreservation 15.48.3. Quarantine 15.48.4. Rederivation 15.48.5. Model-in-licensing 15.48.6. Genetic Testing 15.48.7. Other Services 15.49. Rest of Europe Rat Model Market Forecast, by Therapeutic Area 15.49.1. Toxicology 15.49.2. Oncology 15.49.3. Immunology and Inflammation 15.49.4. Neurology 15.49.5. Diabetes 15.49.6. Other Therapeutic Areas 15.50. Rest Of Europe Rat Model Market Forecast, by Care Product 15.50.1. Cages 15.50.2. Feed 15.50.3. Bedding 15.50.4. Others 15.51. Rest Of Europe Rat Model Market Forecast, by End-user 15.51.1. Pharmaceutical & Biotechnology Companies 15.51.2. Academic & Research Institutes 15.51.3. Contract Research Organizations (CROs) 15.52. Rest Of Europe Rat Model Market Forecast, by Technology 15.52.1. CRISPR 15.52.2. Microinjection 15.52.3. Embryonic Stem Cell 15.52.4. Nuclear Transfer 15.53. Europe Rat Model Market Attractiveness Analysis 15.53.1. By Model Type 15.53.2. By Service 15.53.3. By Therapeutic Area 15.53.4. By Care Product 15.53.5. By End-user 15.54. PEST Analysis 15.55. Key Trends 15.56. Key Developments 16. Asia Pacific Rat Model Market Analysis 16.1. Key Findings 16.2. Asia Pacific Rat Model Market Overview 16.3. Asia Pacific Rat Model Market Value Share Analysis, by Model Type 16.4. Asia Pacific Rat Model Market Forecast, by Model Type 16.4.1. Outbred Rats 16.4.2. Inbred Rats 16.4.3. Knockout/Genetically Modified Rats 16.4.4. Hybrid/Congenic Rats 16.4.5. Conditioned/Surgically Modified Rats 16.4.6. Immunodeficient Rats 16.5. Asia Pacific Rat Model Market Value Share Analysis, by Service 16.6. Asia Pacific Rat Model Market Forecast, by Service 16.6.1. Breeding 16.6.2. Cryopreservation 16.6.3. Quarantine 16.6.4. Rederivation 16.6.5. Model-in-licensing 16.6.6. Genetic Testing 16.6.7. Other Services 16.7. Asia Pacific Rat Model Market Value Share Analysis, by Therapeutic Area 16.8. Asia Pacific Rat Model Market Forecast, by Therapeutic Area 16.8.1. Toxicology 16.8.2. Oncology 16.8.3. Immunology and Inflammation 16.8.4. Neurology 16.8.5. Diabetes 16.8.6. Other Therapeutic Areas 16.9. Asia Pacific Rat Model Market Value Share Analysis, by Care Product 16.10. Asia Pacific Rat Model Market Forecast, by Care Product 16.10.1. Cages 16.10.2. Feed 16.10.3. Bedding 16.10.4. Others 16.11. Asia Pacific Rat Model Market Value Share Analysis, by End-user 16.12. Asia Pacific Rat Model Market Forecast, by End-user 16.12.1. Pharmaceutical & Biotechnology Companies 16.12.2. Academic & Research Institutes 16.12.3. Contract Research Organizations (CROs) 16.13. Asia Pacific Rat Model Market Value Share Analysis, by Technology 16.14. Asia Pacific Rat Model Market Forecast, by Technology 16.14.1. CRISPR 16.14.2. Microinjection 16.14.3. Embryonic Stem Cell 16.14.4. Nuclear Transfer 16.15. Asia Pacific Rat Model Market Value Share Analysis, by Country 16.16. Asia Pacific Rat Model Market Forecast, by Country 16.16.1. China 16.16.2. India 16.16.3. Japan 16.16.4. ASEAN 16.16.5. Rest of Asia Pacific 16.17. Asia Pacific Rat Model Market Analysis, by Country 16.18. China Rat Model Market Forecast, by Model Type 16.18.1. Outbred Rats 16.18.2. Inbred Rats 16.18.3. Knockout/Genetically Modified Rats 16.18.4. Hybrid/Congenic Rats 16.18.5. Conditioned/Surgically Modified Rats 16.18.6. Immunodeficient Rats 16.19. China Rat Model Market Forecast, by Service 16.19.1. Breeding 16.19.2. Cryopreservation 16.19.3. Quarantine 16.19.4. Rederivation 16.19.5. Model-in-licensing 16.19.6. Genetic Testing 16.19.7. Other Services 16.20. China Rat Model Market Forecast, by Therapeutic Area 16.20.1. Toxicology 16.20.2. Oncology 16.20.3. Immunology and Inflammation 16.20.4. Neurology 16.20.5. Diabetes 16.20.6. Other Therapeutic Areas 16.21. China Rat Model Market Forecast, by Care Product 16.21.1. Cages 16.21.2. Feed 16.21.3. Bedding 16.21.4. Others 16.22. China Rat Model Market Forecast, by End-user 16.22.1. Pharmaceutical & Biotechnology Companies 16.22.2. Academic & Research Institutes 16.22.3. Contract Research Organizations (CROs) 16.23. China Rat Model Market Forecast, by Technology 16.23.1. CRISPR 16.23.2. Microinjection 16.23.3. Embryonic Stem Cell 16.23.4. Nuclear Transfer 16.24. India Rat Model Market Forecast, by Model Type 16.24.1. Outbred Rats 16.24.2. Inbred Rats 16.24.3. Knockout/Genetically Modified Rats 16.24.4. Hybrid/Congenic Rats 16.24.5. Conditioned/Surgically Modified Rats 16.24.6. Immunodeficient Rats 16.25. India Rat Model Market Forecast, by Service 16.25.1. Breeding 16.25.2. Cryopreservation 16.25.3. Quarantine 16.25.4. Rederivation 16.25.5. Model-in-licensing 16.25.6. Genetic Testing 16.25.7. Other Services 16.26. India Rat Model Market Forecast, by Therapeutic Area 16.26.1. Toxicology 16.26.2. Oncology 16.26.3. Immunology and Inflammation 16.26.4. Neurology 16.26.5. Diabetes 16.26.6. Other Therapeutic Areas 16.27. India Rat Model Market Forecast, by Care Product 16.27.1. Cages 16.27.2. Feed 16.27.3. Bedding 16.27.4. Others 16.28. India Rat Model Market Forecast, by End-user 16.28.1. Pharmaceutical & Biotechnology Companies 16.28.2. Academic & Research Institutes 16.28.3. Contract Research Organizations (CROs) 16.29. India Rat Model Market Forecast, by Technology 16.29.1. CRISPR 16.29.2. Microinjection 16.29.3. Embryonic Stem Cell 16.29.4. Nuclear Transfer 16.30. Japan Rat Model Market Forecast, by Model Type 16.30.1. Outbred Rats 16.30.2. Inbred Rats 16.30.3. Knockout/Genetically Modified Rats 16.30.4. Hybrid/Congenic Rats 16.30.5. Conditioned/Surgically Modified Rats 16.30.6. Immunodeficient Rats 16.31. Japan Rat Model Market Forecast, by Service 16.31.1. Breeding 16.31.2. Cryopreservation 16.31.3. Quarantine 16.31.4. Rederivation 16.31.5. Model-in-licensing 16.31.6. Genetic Testing 16.31.7. Other Services 16.32. Japan Rat Model Market Forecast, by Therapeutic Area 16.32.1. Toxicology 16.32.2. Oncology 16.32.3. Immunology and Inflammation 16.32.4. Neurology 16.32.5. Diabetes 16.32.6. Other Therapeutic Areas 16.33. Japan Rat Model Market Forecast, by Care Product 16.33.1. Cages 16.33.2. Feed 16.33.3. Bedding 16.33.4. Others 16.34. Japan Rat Model Market Forecast, by End-user 16.34.1. Pharmaceutical & Biotechnology Companies 16.34.2. Academic & Research Institutes 16.34.3. Contract Research Organizations (CROs) 16.35. Japan Rat Model Market Forecast, by Technology 16.35.1. CRISPR 16.35.2. Microinjection 16.35.3. Embryonic Stem Cell 16.35.4. Nuclear Transfer 16.36. ASEAN Rat Model Market Forecast, by Model Type 16.36.1. Outbred Rats 16.36.2. Inbred Rats 16.36.3. Knockout/Genetically Modified Rats 16.36.4. Hybrid/Congenic Rats 16.36.5. Conditioned/Surgically Modified Rats 16.36.6. Immunodeficient Rats 16.37. ASEAN Rat Model Market Forecast, by Service 16.37.1. Breeding 16.37.2. Cryopreservation 16.37.3. Quarantine 16.37.4. Rederivation 16.37.5. Model-in-licensing 16.37.6. Genetic Testing 16.37.7. Other Services 16.38. ASEAN Rat Model Market Forecast, by Therapeutic Area 16.38.1. Toxicology 16.38.2. Oncology 16.38.3. Immunology and Inflammation 16.38.4. Neurology 16.38.5. Diabetes 16.38.6. Other Therapeutic Areas 16.39. ASEAN Rat Model Market Forecast, by Care Product 16.39.1. Cages 16.39.2. Feed 16.39.3. Bedding 16.39.4. Others 16.40. ASEAN Rat Model Market Forecast, by End-user 16.40.1. Pharmaceutical & Biotechnology Companies 16.40.2. Academic & Research Institutes 16.40.3. Contract Research Organizations (CROs) 16.41. ASEAN Rat Model Market Forecast, by Technology 16.41.1. CRISPR 16.41.2. Microinjection 16.41.3. Embryonic Stem Cell 16.41.4. Nuclear Transfer 16.42. Rest of Asia Pacific Rat Model Market Forecast, by Model Type 16.42.1. Outbred Rats 16.42.2. Inbred Rats 16.42.3. Knockout/Genetically Modified Rats 16.42.4. Hybrid/Congenic Rats 16.42.5. Conditioned/Surgically Modified Rats 16.42.6. Immunodeficient Rats 16.43. Rest of Asia Pacific Rat Model Market Forecast, by Service 16.43.1. Breeding 16.43.2. Cryopreservation 16.43.3. Quarantine 16.43.4. Rederivation 16.43.5. Model-in-licensing 16.43.6. Genetic Testing 16.43.7. Other Services 16.44. Rest of Asia Pacific Rat Model Market Forecast, by Therapeutic Area 16.44.1. Toxicology 16.44.2. Oncology 16.44.3. Immunology and Inflammation 16.44.4. Neurology 16.44.5. Diabetes 16.44.6. Other Therapeutic Areas 16.45. Rest of Asia Pacific Rat Model Market Forecast, by Care Product 16.45.1. Cages 16.45.2. Feed 16.45.3. Bedding 16.45.4. Others 16.46. Rest of Asia Pacific Rat Model Market Forecast, by End-user 16.46.1. Pharmaceutical & Biotechnology Companies 16.46.2. Academic & Research Institutes 16.46.3. Contract Research Organizations (CROs) 16.47. Rest of Asia Pacific Rat Model Market Forecast, by technology 16.47.1. CRISPR 16.47.2. Microinjection 16.47.3. Embryonic Stem Cell 16.47.4. Nuclear Transfer 16.48. Asia Pacific Rat Model Market Attractiveness Analysis 16.48.1. By Model Type 16.48.2. By Service 16.48.3. By Therapeutic Area 16.48.4. By Care Product 16.48.5. By End-user 16.49. PEST Analysis 16.50. Key Trends 16.51. Key Developments 17. Middle East & Africa Rat Model Market Analysis 17.1. Key Findings 17.2. Middle East & Africa Rat Model Market Overview 17.3. Middle East & Africa Rat Model Market Value Share Analysis, by Model Type 17.4. Middle East & Africa Rat Model Market Forecast, by Model Type 17.4.1. Outbred Rats 17.4.2. Inbred Rats 17.4.3. Knockout/Genetically Modified Rats 17.4.4. Hybrid/Congenic Rats 17.4.5. Conditioned/Surgically Modified Rats 17.4.6. Immunodeficient Rats 17.5. Middle East & Africa Rat Model Market Value Share Analysis, by Service 17.6. Middle East & Africa Rat Model Market Forecast, by Service 17.6.1. Breeding 17.6.2. Cryopreservation 17.6.3. Quarantine 17.6.4. Rederivation 17.6.5. Model-in-licensing 17.6.6. Genetic Testing 17.6.7. Other Services 17.7. Middle East & Africa Rat Model Market Value Share Analysis, by Therapeutic Area 17.8. Middle East & Africa Rat Model Market Forecast, by Therapeutic Area 17.8.1. Toxicology 17.8.2. Oncology 17.8.3. Immunology and Inflammation 17.8.4. Neurology 17.8.5. Diabetes 17.8.6. Other Therapeutic Areas 17.9. Middle East & Africa Rat Model Market Value Share Analysis, by Care Product 17.10. Middle East & Africa Rat Model Market Forecast, by Care Product 17.10.1. Cages 17.10.2. Feed 17.10.3. Bedding 17.10.4. Others 17.11. Middle East & Africa Rat Model Market Value Share Analysis, by End-user 17.12. Middle East & Africa Rat Model Market Forecast, by End-user 17.12.1. Pharmaceutical & Biotechnology Companies 17.12.2. Academic & Research Institutes 17.12.3. Contract Research Organizations (CROs) 17.13. Middle East& Africa Rat Model Market Value Share Analysis, by Technology 17.14. Middle East & Africa Rat Model Market Forecast, by Technology 17.14.1. CRISPR 17.14.2. Microinjection 17.14.3. Embryonic Stem Cell 17.14.4. Nuclear Transfer 17.15. Middle East & Africa Rat Model Market Value Share Analysis, by Country 17.16. Middle East & Africa Rat Model Market Forecast, by Country 17.16.1. GCC 17.16.2. South Africa 17.16.3. Rest of Middle East & Africa 17.17. Middle East & Africa Rat Model Market Analysis, by Country 17.18. GCC Rat Model Market Forecast, by Model Type 17.18.1. Outbred Rats 17.18.2. Inbred Rats 17.18.3. Knockout/Genetically Modified Rats 17.18.4. Hybrid/Congenic Rats 17.18.5. Conditioned/Surgically Modified Rats 17.18.6. Immunodeficient Rats 17.19. GCC Rat Model Market Forecast, by Service 17.19.1. Breeding 17.19.2. Cryopreservation 17.19.3. Quarantine 17.19.4. Rederivation 17.19.5. Model-in-licensing 17.19.6. Genetic Testing 17.19.7. Other Services 17.20. GCC Rat Model Market Forecast, by Therapeutic Area 17.20.1. Toxicology 17.20.2. Oncology 17.20.3. Immunology and Inflammation 17.20.4. Neurology 17.20.5. Diabetes 17.20.6. Other Therapeutic Areas 17.21. GCC Rat Model Market Forecast, by Care Product 17.21.1. Cages 17.21.2. Feed 17.21.3. Bedding 17.21.4. Others 17.22. GCC Rat Model Market Forecast, by End-user 17.22.1. Pharmaceutical & Biotechnology Companies 17.22.2. Academic & Research Institutes 17.22.3. Contract Research Organizations (CROs) 17.23. GCC Rat Model Market Forecast, by Technology 17.23.1. CRISPR 17.23.2. Microinjection 17.23.3. Embryonic Stem Cell 17.23.4. Nuclear Transfer 17.24. South Africa Rat Model Market Forecast, by Model Type 17.24.1. Outbred Rats 17.24.2. Inbred Rats 17.24.3. Knockout/Genetically Modified Rats 17.24.4. Hybrid/Congenic Rats 17.24.5. Conditioned/Surgically Modified Rats 17.24.6. Immunodeficient Rats 17.25. South Africa Rat Model Market Forecast, by Service 17.25.1. Breeding 17.25.2. Cryopreservation 17.25.3. Quarantine 17.25.4. Rederivation 17.25.5. Model-in-licensing 17.25.6. Genetic Testing 17.25.7. Other Services 17.26. South Africa Rat Model Market Forecast, by Therapeutic Area 17.26.1. Toxicology 17.26.2. Oncology 17.26.3. Immunology and Inflammation 17.26.4. Neurology 17.26.5. Diabetes 17.26.6. Other Therapeutic Areas 17.27. South Africa Rat Model Market Forecast, by Care Product 17.27.1. Cages 17.27.2. Feed 17.27.3. Bedding 17.27.4. Others 17.28. South Africa Rat Model Market Forecast, by End-user 17.28.1. Pharmaceutical & Biotechnology Companies 17.28.2. Academic & Research Institutes 17.28.3. Contract Research Organizations (CROs) 17.29. South Africa Rat Model Market Forecast, by Technolgy 17.29.1. CRISPR 17.29.2. Microinjection 17.29.3. Embryonic Stem Cell 17.29.4. Nuclear Transfer 17.30. Rest of Middle East & Africa Rat Model Market Forecast, by Model Type 17.30.1. Outbred Rats 17.30.2. Inbred Rats 17.30.3. Knockout/Genetically Modified Rats 17.30.4. Hybrid/Congenic Rats 17.30.5. Conditioned/Surgically Modified Rats 17.30.6. Immunodeficient Rats 17.31. Rest of Middle East & Africa Rat Model Market Forecast, by Service 17.31.1. Breeding 17.31.2. Cryopreservation 17.31.3. Quarantine 17.31.4. Rederivation 17.31.5. Model-in-licensing 17.31.6. Genetic Testing 17.31.7. Other Services 17.32. Rest of Middle East & Africa Rat Model Market Forecast, by Therapeutic Area 17.32.1. Toxicology 17.32.2. Oncology 17.32.3. Immunology and Inflammation 17.32.4. Neurology 17.32.5. Diabetes 17.32.6. Other Therapeutic Areas 17.33. Rest of Middle East & Africa Rat Model Market Forecast, by Care Product 17.33.1. Cages 17.33.2. Feed 17.33.3. Bedding 17.33.4. Others 17.34. Rest of Middle East & Africa Rat Model Market Forecast, by End-user 17.34.1. Pharmaceutical & Biotechnology Companies 17.34.2. Academic & Research Institutes 17.34.3. Contract Research Organizations (CROs) 17.35. Rest of Middle East & Africa Rat Model Market Forecast, by Technology 17.35.1. CRISPR 17.35.2. Microinjection 17.35.3. Embryonic Stem Cell 17.35.4. Nuclear Transfer 17.36. Middle East & Africa Rat Model Market Attractiveness Analysis 17.36.1. By Model Type 17.36.2. By Service 17.36.3. By Therapeutic Area 17.36.4. By Care Product 17.36.5. By End-user 17.37. PEST Analysis 17.38. Key Trends 17.39. Key Developments 18. South America Rat Model Market Analysis 18.1. Key Findings 18.2. South America Rat Model Market Overview 18.3. South America Rat Model Market Value Share Analysis, by Model Type 18.4. South America Rat Model Market Forecast, by Model Type 18.4.1. Outbred Rats 18.4.2. Inbred Rats 18.4.3. Knockout/Genetically Modified Rats 18.4.4. Hybrid/Congenic Rats 18.4.5. Conditioned/Surgically Modified Rats 18.4.6. Immunodeficient Rats 18.5. South America Rat Model Market Value Share Analysis, by Service 18.6. South America Rat Model Market Forecast, by Service 18.6.1. Breeding 18.6.2. Cryopreservation 18.6.3. Quarantine 18.6.4. Rederivation 18.6.5. Model-in-licensing 18.6.6. Genetic Testing 18.6.7. Other Services 18.7. South America Rat Model Market Value Share Analysis, by Therapeutic Area 18.8. South America Rat Model Market Forecast, by Therapeutic Area 18.8.1. Toxicology 18.8.2. Oncology 18.8.3. Immunology and Inflammation 18.8.4. Neurology 18.8.5. Diabetes 18.8.6. Other Therapeutic Areas 18.9. South America Rat Model Market Value Share Analysis, by Care Product 18.10. South America Rat Model Market Forecast, by Care Product 18.10.1. Cages 18.10.2. Feed 18.10.3. Bedding 18.10.4. Others 18.11. South America Rat Model Market Value Share Analysis, by End-user 18.12. South America Rat Model Market Forecast, by End-user 18.12.1. Pharmaceutical & Biotechnology Companies 18.12.2. Academic & Research Institutes 18.12.3. Contract Research Organizations (CROs) 18.13. South America Rat Model Market Value Share Analysis, by Technology 18.14. South America Rat Model Market Forecast, by Technology 18.14.1. CRISPR 18.14.2. Microinjection 18.14.3. Embryonic Stem Cell 18.14.4. Nuclear Transfer 18.15. South America Rat Model Market Value Share Analysis, by Country 18.16. South America Rat Model Market Forecast, by Country 18.16.1. Brazil 18.16.2. Mexico 18.16.3. Rest of South America 18.17. South America Rat Model Market Analysis, by Country 18.18. Brazil Rat Model Market Forecast, by Model Type 18.18.1. Outbred Rats 18.18.2. Inbred Rats 18.18.3. Knockout/Genetically Modified Rats 18.18.4. Hybrid/Congenic Rats 18.18.5. Conditioned/Surgically Modified Rats 18.18.6. Immunodeficient Rats 18.19. Brazil Rat Model Market Forecast, by Service 18.19.1. Breeding 18.19.2. Cryopreservation 18.19.3. Quarantine 18.19.4. Rederivation 18.19.5. Model-in-licensing 18.19.6. Genetic Testing 18.19.7. Other Services 18.20. Brazil Rat Model Market Forecast, by Therapeutic Area 18.20.1. Toxicology 18.20.2. Oncology 18.20.3. Immunology and Inflammation 18.20.4. Neurology 18.20.5. Diabetes 18.20.6. Other Therapeutic Areas 18.21. Brazil Rat Model Market Forecast, by Care Product 18.21.1. Cages 18.21.2. Feed 18.21.3. Bedding 18.21.4. Others 18.22. Brazil Rat Model Market Forecast, by End-user 18.22.1. Pharmaceutical & Biotechnology Companies 18.22.2. Academic & Research Institutes 18.22.3. Contract Research Organizations (CROs) 18.23. Brazil Rat Model Market Forecast, by Technology 18.23.1. CRISPR 18.23.2. Microinjection 18.23.3. Embryonic Stem Cell 18.23.4. Nuclear Transfer 18.24. Mexico Rat Model Market Forecast, by Model Type 18.24.1. Outbred Rats 18.24.2. Inbred Rats 18.24.3. Knockout/Genetically Modified Rats 18.24.4. Hybrid/Congenic Rats 18.24.5. Conditioned/Surgically Modified Rats 18.24.6. Immunodeficient Rats 18.25. Mexico Rat Model Market Forecast, by Service 18.25.1. Breeding 18.25.2. Cryopreservation 18.25.3. Quarantine 18.25.4. Rederivation 18.25.5. Model-in-licensing 18.25.6. Genetic Testing 18.25.7. Other Services 18.26. Mexico Rat Model Market Forecast, by Therapeutic Area 18.26.1. Toxicology 18.26.2. Oncology 18.26.3. Immunology and Inflammation 18.26.4. Neurology 18.26.5. Diabetes 18.26.6. Other Therapeutic Areas 18.27. Mexico Rat Model Market Forecast, by Care Product 18.27.1. Cages 18.27.2. Feed 18.27.3. Bedding 18.27.4. Others 18.28. Mexico Rat Model Market Forecast, by End-user 18.28.1. Pharmaceutical & Biotechnology Companies 18.28.2. Academic & Research Institutes 18.28.3. Contract Research Organizations (CROs) 18.29. Mexico Rat Model Market Forecast, by Technology 18.29.1. CRISPR 18.29.2. Microinjection 18.29.3. Embryonic Stem Cell 18.29.4. Nuclear Transfer 18.30. Mexico Rat Model Market Forecast, by End-user 18.30.1. CRISPR 18.30.2. Microinjection 18.30.3. Embryonic Stem Cell 18.30.4. Nuclear Transfer 18.31. Rest of South America Rat Model Market Forecast, by Model Type 18.31.1. Outbred Rats 18.31.2. Inbred Rats 18.31.3. Knockout/Genetically Modified Rats 18.31.4. Hybrid/Congenic Rats 18.31.5. Conditioned/Surgically Modified Rats 18.31.6. Immunodeficient Rats 18.32. Rest of South America Rat Model Market Forecast, by Service 18.32.1. Breeding 18.32.2. Cryopreservation 18.32.3. Quarantine 18.32.4. Rederivation 18.32.5. Model-in-licensing 18.32.6. Genetic Testing 18.32.7. Other Services 18.33. Rest of South America Rat Model Market Forecast, by Therapeutic Area 18.33.1. Toxicology 18.33.2. Oncology 18.33.3. Immunology and Inflammation 18.33.4. Neurology 18.33.5. Diabetes 18.33.6. Other Therapeutic Areas 18.34. Rest of South America Rat Model Market Forecast, by Care Product 18.34.1. Cages 18.34.2. Feed 18.34.3. Bedding 18.34.4. Others 18.35. Rest of South America Rat Model Market Forecast, by End-user 18.35.1. Pharmaceutical & Biotechnology Companies 18.35.2. Academic & Research Institutes 18.35.3. Contract Research Organizations (CROs) 18.36. Rest of South America Rat Model Market Forecast, by Technology 18.36.1. CRISPR 18.36.2. Microinjection 18.36.3. Embryonic Stem Cell 18.36.4. Nuclear Transfer 18.37. South America Rat Model Market Attractiveness Analysis 18.37.1. By Model Type 18.37.2. By Service 18.37.3. By Therapeutic Area 18.37.4. By Care Product 18.37.5. By End-user 18.38. PEST Analysis 18.39. Key Trends 18.40. Key Developments 19. Company Profiles 19.1. Market Share Analysis, by Company 19.2. Competition Matrix 19.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 19.2.2. New Product Launches and Product Enhancements 19.2.3. Market Consolidation 19.2.3.1. M&A by Regions, Investment and Applications 19.2.3.2. M&A Key Players, Forward Integration and Backward Integration 19.3. Company Profiles: Key Players 19.3.1. Genoway S.A 19.3.1.1. Company Overview 19.3.1.2. Financial Overview 19.3.1.3. Product Portfolio 19.3.1.4. Business Strategy 19.3.1.5. Recent Developments 19.3.1.6. Developing Footprint 19.3.2. Biomere 19.3.3. Transposagen Biopharmaceuticals, Inc. 19.3.4. Horizon Discovery Group PLC 19.3.5. Transviragen, Inc. 19.3.6. Charles River Laboratories International, Inc. 19.3.7. Taconic Biosciences, Inc. 19.3.8. Envigo 19.3.9. Laboratory Corporation of America Holdings 19.3.10. Janvier Labs 19.3.11. Harlan Laboratories, Inc. 19.3.12. SAGE Labs 19.3.13. Applied StemCell 19.3.14. Regenera Pharma 19.3.15. Active C60 20. Primary Key Insights